These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 12214267)
1. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins. Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682 [TBL] [Abstract][Full Text] [Related]
3. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M. Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310 [TBL] [Abstract][Full Text] [Related]
4. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies. Murakami-Mori K; Taga T; Kishimoto T; Nakamura S J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate. Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520 [TBL] [Abstract][Full Text] [Related]
7. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells. Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575 [TBL] [Abstract][Full Text] [Related]
8. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor. Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716 [TBL] [Abstract][Full Text] [Related]
9. Expression and production of interleukin 10 in human myeloma cell lines. Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145 [TBL] [Abstract][Full Text] [Related]
10. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors. Malaval L; Liu F; Vernallis AB; Aubin JE J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050 [TBL] [Abstract][Full Text] [Related]
11. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. Qi H; Ratnam M Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727 [TBL] [Abstract][Full Text] [Related]
12. [Signal of the cytoplasmic regions of leukemia inhibitory factor receptor (LIFR) alpha-subunit and gp130 involves Stat3 activation in leukemic U937 cells]. Liu H; Tang S; Liu S Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):621-3. PubMed ID: 11721361 [TBL] [Abstract][Full Text] [Related]
13. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas. Savarese TM; Campbell CL; McQuain C; Mitchell K; Guardiani R; Quesenberry PJ; Nelson BE Cytokine; 2002 Mar; 17(6):324-34. PubMed ID: 12061840 [TBL] [Abstract][Full Text] [Related]
14. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells. Grant SL; Hammacher A; Douglas AM; Goss GA; Mansfield RK; Heath JK; Begley CG Oncogene; 2002 Jan; 21(3):460-74. PubMed ID: 11821958 [TBL] [Abstract][Full Text] [Related]
15. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism. Hui W; Bell M; Carroll G Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300 [TBL] [Abstract][Full Text] [Related]
16. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Nakajima H; Kim YB; Terano H; Yoshida M; Horinouchi S Exp Cell Res; 1998 May; 241(1):126-33. PubMed ID: 9633520 [TBL] [Abstract][Full Text] [Related]
17. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404 [TBL] [Abstract][Full Text] [Related]
18. Loss of oncostatin M receptor beta in metastatic melanoma cells. Lacreusette A; Nguyen JM; Pandolfino MC; Khammari A; Dreno B; Jacques Y; Godard A; Blanchard F Oncogene; 2007 Feb; 26(6):881-92. PubMed ID: 16909117 [TBL] [Abstract][Full Text] [Related]
19. A selective switch-on system for self-renewal of embryonic stem cells using chimeric cytokine receptors. Nakamura T; Arai T; Takagi M; Sawada T; Matsuda T; Yokota T; Heike T Biochem Biophys Res Commun; 1998 Jul; 248(1):22-7. PubMed ID: 9675079 [TBL] [Abstract][Full Text] [Related]
20. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family. Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]